The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice

B. Dymek (Warszawa, Poland)

Source: International Congress 2017 – Asthma: mechanisms and treatment
Session: Asthma: mechanisms and treatment
Session type: Poster Discussion
Number: 4684
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Dymek (Warszawa, Poland). The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice. 4684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of budesonide/formoterol combination on an airway hyperresponsiveness and inflammation model in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008

Evaluation of apoptosis in inflammatory cells in a model of chronic airway inflammation in guinea pigs: effects of dexamethasone and montelukast treatments
Source: Eur Respir J 2003; 22: Suppl. 45, 281s
Year: 2003

HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008


Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice
Source: Eur Respir J 2001; 18: Suppl. 33, 30s
Year: 2001

Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Comparison of anti-IL-9 and anti-IL-5 treatment efficacy in a mouse model of airway eosinophilic inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 482s
Year: 2003

Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 24s
Year: 2007

Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

The airway inflammatory response in allergic mice is downregulated by budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001

PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008

Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018

A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002

Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide
Source: International Congress 2018 – Basic pharmacology
Year: 2018

LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009

Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF-induced murine model of asthma
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


A cyclosporin A/maltosyl-α-cyclodextrin complex for inhalation therapy of asthma
Source: Eur Respir J 2003; 22: 213-219
Year: 2003